A meta-analysis of interferon-α treatment of hepatitis D virus infection

Pharmacotherapy

Volumn 16, Issue 4, 1996, Pages 609-614

  Malaguarnera, Mariano ^a,b   Restuccia, Salvatore ^a   Pistone, Giovanni ^a   Ruello, Pasqualina ^a   Giugno, Ignazio ^a   Trovato, Barbara A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LYMPHOBLAST INTERFERON; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ALPHA2C INTERFERON;

CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DRUG EFFICACY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; STATISTICAL ANALYSIS;

ANTIVIRAL AGENTS; CHRONIC DISEASE; HEPATITIS D; HUMANS; INTERFERON-ALPHA;

EID: 0029825879     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of a new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977;18:997-1003.
2. Rizzetto M, Hoyer BH, Purcell RH, et al. Hepatitis delta virus infection. In: Vyas GN, Dienstag J, Hoofnagle JH, eds. Viral hepatitis and liver disease. New York: Grune & Stratton, 1984:371-7.
3. Gerin JL. Hepatitis D virus. American Association for the Study of Liver Disease postgraduate course, Chicago, November 11-12, 1994.
4. Caredda F, Antinori S, Re T, Pastecchia C, Moroni M. Course and prognosis of acute HDV hepatitis. Prog Clin Biol Res 1987;234:267-70.
5. Govindarajan S, Valinluk B, Peters R. Relapse of acute B viral hepatitis. Role of delta agent. Gut 1986;27:19-23.
6. Farci P, Smedile A, Lavarini C, et al. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. Gastroenterology 1983;85:669-74.
7. Saracco G, Mazzella G, Rosina F. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989;10:336-41.
8. Moestrup T, Hansson BG, Widell A, Nordenfelt E. Clinical aspects of delta infection. Br Med J 1983;286:87-90.
9. Caredda F, Rossi E, D'Arminio Monforte A, et al. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis 1985;151:925-8.
10. Di Bisceglie AM. Hepatitis D: course, therapy and prevention. American Association for the Study of Liver Disease postgraduate course, Chicago, November 11-12, 1994.
11. Rosina F, Rizzetto M. Treatment of chronic type D (delta) hepatitis with alpha interferon. Semin Liver Dis 1989;9(4):264-6.
12. Hoofnagle JH, Mullen KD, Peters M, et al. Treatment of chronic delta hepatitis with recombinant human alpha interferon. In: Stewart WE, Schellekens H, eds. The biology of the interferon system. Amsterdam: Elsevier, 1985:493-5.
13. Rosina F, Saracco G., Lattore V, et al. Alpha 2 recombinant interferon in the treatment of chronic hepatilis delta virus (HDV). Prog Clin Biol Res 1987;234:299-303.
14. Thomas HC, Farci P, Shein R, et al. Inhibition of hepatitis delta virus replication by lymphoblastoid human alpha interferon. Prog Clin Biol Res 1987;234:277-90.
15. Marzano A, Ottobrelli A, Spezia C, Daziano E, Soranzo ML, Rizzetto M. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study. Ital J Gastroenterol 1992;24(3):119-21.
16. Madejon A, Cotonat T, Bartolome J, Castillo I, Carreno V. Treatment of chronic hepatitis D virus infection with low and high doses of interferon alpha-2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology 1994;19(6):1331-6.
17. Amitrano L, Addario L, D'Agostino S, et al. Terapia dell'epatite cronica delta con 2 differenti schemi terapeutici di Interferon alfa 2 ricombinante. In: Giusti G, Piccinino F, Galanti B, Gaeta GB, eds. Le epatiti croniche virali. Storia naturale e terapia. Milano, Italy: Masson, 1992:123-33.
18. Hadziyannis SJ. Use of alpha interferon in the treatment of chronic delta hepatitis. J Hepatol 1991;13:S21-6.
19. Di Bisceglie AM, Martin P, Lisker-Melman M, et al. Therapy of chronic delta hepatitis with interferon alpha 2b. J Hepatol 1990;11:S149-50.
20. Hoofnagle JH, Mullen KD, Peters M, et al. Treatment of chronic delta hepatitis with recombinant human alpha interferon. Prog Clin Biol Res 1987;234:291-8.
21. Antonov K, Naoumov N, Krastev Z. Two years after treatment of chronic hepatitis delta virus (HDV) infection with recombinant human alpha-interferon [abstr]. Abstracts of the 29th annual meeting of the European Association for the Study of the Liver, September 7-10, 1994, Athens, Greece. J Hepatol 1994;21(suppl 1):S96.
22. Marinucci G, Hassan G, Di Giacomo C, et al. Alpha recombinant interferon therapy in chronic delta hepatitis: an experience of long term treatment [abstr]. International Symposium on Viral Hepatitis and Liver Disease (7th triennal congress), Scientific Program and Abstracts, Houston, April 4-8, 1990.
23. Lampertico P, Emanuelli B, De Filippi F, et al. Quantitative IgM anti-HDV assay in patients with chronic hepatitis delta treated with interferon: a correlation with biochemical markers of liver damage. Abstracts of the 29th annual meeting of the European Association for the Study of the Liver, September 7-10, 1994, Athens, Greece. J Hepatol 1994;21(suppl 1):S112.
24. Faure P, Gaudin JL, Naouri C, et al. Treatment of chronic active delta hepatitis with recombinant alpha interferon [abstr]. International Symposium on Viral Hepatitis and Liver Disease (7th triennal congress), Scientific Program and Abstracts, Houston, April 4-8, 1990.
25. Farci P, Mandas A, Lai ME, et al. Treatment of chronic delta hepatitis with high and low doses of interferon alpha 2a. A randomized controlled trial [abstr]. Hepatology 1990;12:869.
26. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant interferon alpha in chronic delta (type delta) hepatitis: a multicenter Italian study. Hepatology 1991;13(6):1052-16.
27. Porres JC, Carreno V, Bartholome J, Moreno A, Galiana F, Quiroga JA. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses. J Hepatol 1989;9:338-50.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
29. Bonino F, Caporaso N, Dentico P, et al. Familiar clustering and spreading of hepatitis delta virus infection. J Hepatol 1985;1:221-6.
30. Aragona M, Macagno S, Caredda F, et al. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance. In: Rizzetto M, Gerin JL, Purcell RH, eds. The hepatitis delta virus and its infection. New York: Alan R. Liss, 1987:277-90.
31. Dimitrikakis M, Waters MJ, Wottern A, Gust ID. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus. J Med Virol 1986;20: 305-8.
32. Rizzetto M, Verme G, Gerin JL, Purcell RH. Hepatitis delta virus disease. Prog Liver Dis 1986;8:417-31.